Operand Raises $31M Across Seed and Series A Funding

Operand describes its job through 2 connected activities: developing investment theses and working on companies after acquisition. The San Francisco startup is applying AI research to a relationship that reaches from considering an investment to helping an investor understand the business it has bought.

The financing gives that ambition more resources. Axios reported on November 10, 2026 that Operand had raised $31M across seed and Series A. In a separate statement reposted by Operand and Khosla Ventures, CEO and co-founder Ram Gorthi described a recently closed $30M financing led by Khosla Ventures at a $220M valuation, with Keith Rabois joining the board. Those accounts describe different funding scopes and leave the allocation between rounds unstated.

Gorthi founded Operand with Akhil Iyengar and Arjun Sahney. The company is part of Y Combinator's Winter 2025 batch, and its current positioning puts AI close to a consequential customer decision: which assumptions deserve to carry an acquisition, and which operating decisions follow when the buyer takes ownership.

What Operand's financing supports

The founder's financing statement says the capital will accelerate Operand's work with major capital allocators before and after investment. It gives the company a broad commercial remit without laying out a spending budget, hiring target or geographic expansion plan. Khosla Ventures' lead role and Keith Rabois' board appointment bring the investor into that next stage of company building.

The funding needs to be read with its original accounting intact. The $31M figure covers seed and Series A together, while Gorthi's $30M statement concerns a recent financing. A reader should not turn those figures into a $31M Series A, add them together, or infer a seed allocation from the difference. The available announcements do not establish those calculations or identify the exact closing date of each round.

Operand's founding history is clearer. Y Combinator's company profile lists 2024 as the founding year and identifies Gorthi, Iyengar and Sahney as active founders. That makes this a young company attempting to sell into a customer relationship with substantial consequences: research can influence both the decision to buy and the work assigned to management afterward. The financing supports the company's effort to earn a place in that relationship, with commercial performance still dependent on what its research helps customers do.

From pricing work to private-market research

An earlier part of Operand's business remains visible in its investor record. Felicis' portfolio lists Operand as a seed investment and describes an AI consultancy for retailers, while the company's current materials emphasize alternative asset managers and post-acquisition work. The earlier description supplies useful history; the current company account is the stronger guide to its present positioning.

That history makes the private-markets focus easier to understand. Pricing sits at an uncomfortable junction between an investment case and the daily running of a business. An investor can underwrite an opportunity to improve margins, but an operating team still has to decide which customer relationships, products and prices can support the change. This is an analytical connection between the company's earlier and current work, rather than a claim about a particular Operand engagement.

For a founder selling AI research, that junction also changes the commercial conversation. A potential buyer may want a clearer view of an acquisition target; the same institution may later need help assessing an operating choice. Serving both moments creates an opportunity for continuity, provided the research remains useful as the question changes. Operand's stated scope gives the company a reason to stay in the conversation after a transaction, when the assumptions behind the purchase begin meeting the business as it operates.

The technical work behind the research ambition

Operand says it trains models and agents to perform research at scale. A public piece of its technical record is Operand Quant, a paper submitted in October 2025 by Arjun Sahney, Ram Gorthi, Cezary Łastowski and Javier Vega. The paper describes a single-agent system that carries out machine learning engineering work inside an integrated development environment.

That research helps explain the team's interest in systems that can sustain a sequence of technical tasks. It concerns machine learning engineering, however, and its reported benchmark result should stay attached to that task and publication date. A historical research result cannot stand in for evidence about a private-equity customer's investment performance, and the financing announcement supplies no such performance comparison.

For an investment professional, the usefulness of AI research depends on more than the volume of material processed. DevCuration's coverage of BlueMatrix and Aiera follows a related problem in institutional research: keeping the source of an answer visible as analysis moves into AI tools. An answer has to survive questions about its evidence, assumptions and relevance to the decision in front of the firm. This is a practical implication of Operand's chosen market, rather than a claim that the company has disclosed a particular verification feature. A system that can investigate more possibilities gives a buyer more to examine; the commercial value comes from making that examination productive within the investor's actual work.

The operating relationship after a deal

The most consequential part of Operand's positioning may be the duration of the assignment. Work that begins while evaluating a company can establish a record of assumptions an owner will revisit as management makes decisions. That gives the relationship somewhere to go after the acquisition announcement has passed.

It also places the company between people whose responsibilities evolve. The investor assessing a business has a transaction to consider, while the management team inside an acquired company has customers, employees and operating constraints to navigate. Useful research has to remain intelligible as those priorities enter the discussion. The founders' before-and-after-investment scope makes that changing audience part of the commercial opportunity.

The public funding materials leave revenue, named current customers and independently audited investment outcomes unspecified. Gorthi's stated use of the financing nevertheless gives the company a concrete direction: deeper work with capital allocators across the ownership cycle. As Operand develops that business, a finding produced during diligence may return in a more practical form, with an operating team asking how it should affect the next decision inside the company. That is where the research relationship can keep developing long after the capital has changed hands.